Chemoinformaics analysis of Ginsenoyne A linoleate
| Molecular Weight | 530.611 | nRot | 5 |
| Heavy Atom Molecular Weight | 488.275 | nRig | 17 |
| Exact Molecular Weight | 530.273 | nRing | 6 |
| Solubility: LogS | -3.324 | nHRing | 2 |
| Solubility: LogP | 2.296 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 0 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 5 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 80.2473 |
| nHD | 8 | BPOL | 47.3427 |
| QED | 0.599 |
| Synth | 4.652 |
| Natural Product Likeliness | 3.092 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.59 |
| MDCK | 0.000018 |
| BBB | 0.878 |
| PPB | 0.616454 |
| VDSS | 0.863 |
| FU | 0.540327 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.241 |
| CYP2c19-inh | 0.117 |
| CYP2c19-sub | 0.88 |
| CYP2c9-inh | 0.058 |
| CYP2c9-sub | 0.387 |
| CYP2d6-inh | 0.05 |
| CYP2d6-sub | 0.751 |
| CYP3a4-inh | 0.545 |
| CYP3a4-sub | 0.652 |
| CL | 10.714 |
| T12 | 0.61 |
| hERG | 0.023 |
| Ames | 0.057 |
| ROA | 0.153 |
| SkinSen | 0.046 |
| Carcinogencity | 0.982 |
| EI | 0.052 |
| Respiratory | 0.908 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.764523 |